Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Current Assets (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 15 years of Current Assets data on record, last reported at $85.7 million in Q2 2025.

  • For Q2 2025, Current Assets rose 5.73% year-over-year to $85.7 million; the TTM value through May 2025 reached $85.7 million, up 5.73%, while the annual FY2025 figure was $85.7 million, 5.73% up from the prior year.
  • Current Assets reached $85.7 million in Q2 2025 per LFCR's latest filing, up from $84.2 million in the prior quarter.
  • Across five years, Current Assets topped out at $162.9 million in Q1 2021 and bottomed at $74.2 million in Q3 2024.
  • Average Current Assets over 5 years is $106.5 million, with a median of $91.2 million recorded in 2023.
  • Peak YoY movement for Current Assets: plummeted 35.58% in 2023, then increased 10.58% in 2025.
  • A 5-year view of Current Assets shows it stood at $154.5 million in 2021, then decreased by 22.94% to $119.1 million in 2022, then tumbled by 35.58% to $76.7 million in 2023, then grew by 6.71% to $81.9 million in 2024, then grew by 4.67% to $85.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $85.7 million in Q2 2025, $84.2 million in Q1 2025, and $81.9 million in Q4 2024.